Deal snapshot: Ipsen to Acquire US Drugmaker Epizyme for USD 247m.

MANews-(C)2009-2022

French drugmaker Ipsen (Euronext: IPN) (OTC: IPSEY) and US-based Epizyme (NASDAQ: EPZM) have entered into a definitive merger agreement under which Ipsen will acquire Epizyme, the companies said.

The transaction was unanimously approved by both Ipsen and Epizyme Boards of directors and is anticipated to close by the end of 3Q22, subject to the satisfaction of all closing...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT